Literature DB >> 25962847

Tumor suppressor Menin acts as a corepressor of LXRα to inhibit hepatic lipogenesis.

Peng Cheng1, Gang Li1, Sheng Sheng Yang2, Rui Liu1, Gang Jin3, Xu Yu Zhou4, Xian Gui Hu1.   

Abstract

Menin, encoded by the MEN1 gene, was initially identified as a tumor suppressor for endocrine neoplasia. Our previous report showed that Menin enhances PPARα transactivity preventing triglyceride accumulation in the liver. Here, we further explore the role of Menin in liver steatosis. Transient transfection assays demonstrate that Menin inhibits the transcriptional activity of nuclear receptor liver X receptor α (LXRα). Accordingly, Menin overexpression results in reduced expression of LXRα target genes, such as lipogenic enzymes including SREBP-1c, FASN and SCD-1. Co-immunoprecipitation assays revealed physical interaction between Menin and LXRα. Collectively, our data suggest that Menin acts as a novel corepressor of LXRα and functions as a negative regulator of hepatic lipogenesis.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Hepatic lipogenesis; Liver X receptor α; Menin

Mesh:

Substances:

Year:  2015        PMID: 25962847     DOI: 10.1016/j.febslet.2015.04.049

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

Review 1.  Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1.

Authors:  Koen M A Dreijerink; H T Marc Timmers; Myles Brown
Journal:  Endocr Relat Cancer       Date:  2017-08-15       Impact factor: 5.678

Review 2.  Epigenetic Regulation of Hepatic Lipogenesis: Role in Hepatosteatosis and Diabetes.

Authors:  Jose Viscarra; Hei Sook Sul
Journal:  Diabetes       Date:  2020-04       Impact factor: 9.461

Review 3.  The future: genetics advances in MEN1 therapeutic approaches and management strategies.

Authors:  Sunita K Agarwal
Journal:  Endocr Relat Cancer       Date:  2017-10       Impact factor: 5.678

4.  Multiple endocrine neoplasia type 1 combined with thyroid neoplasm: A case report and review of literatures.

Authors:  Jia-Lu Xu; Su Dong; Le-Le Sun; Jin-Xin Zhu; Jia Liu
Journal:  World J Clin Cases       Date:  2022-01-21       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.